Now is the Time to Bolster your Pharma Patent
and Biotech Strategies!
With an alarming increase in the number of litigation cases within the pharmaceutical and
biotech industry, the pressure has never been greater to safeguard patents and protect
revenue streams.
Join us at The Canadian Institute’s 9th Annual Forum on Pharma Patents to stay informed
about the law and benefit from in-depth analysis and strategic advice offered by our
outstanding faculty of speakers representing both brand and generic perspectives.
Highlights from this year’s agenda include:
• Getting patent approval and avoiding invalidity by meeting the anticipation and obviousness standard
• Using access to information requests to advance the interests of your clients
• Clarifying the jurisdiction of the PMPRB when marketing products in Canada
• How to successfully protect exclusivity in the patent/regulatory framework
• Avoiding drug patent invalidity by meeting the duty of good faith patent prosecution post Lundbeck Canada Inc.
…and much more!
Plus, don’t forget to register for our pre-conference workshop on Structuring Biologic
Patents for Maximum Life and Value where you will receive invaluable insight into
regulatory guidelines, including an in-depth analysis of the different approval pathway
systems in Canada as compared to the U.S. and E.U, I.P. protection and current and future
business opportunities.
We look forward to meeting you at the conference!
Conference Details
